FIELD: medicine; cardiology.
SUBSTANCE: inventionrepresents medication, which contains biologically active base, namely bromide 1-(β-phenylethyl-4-("п"-dimethylaminobenzylidenamino) 1,2,4-triazol and shape-forming component, namely water for injections.
EFFECT: increase of treatment efficiency, in comparison with use of traditional medications.
3 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE (MT) | 2008 |
|
RU2404974C2 |
| 1-(β-PHENYLETHYL)-4-(PARA-DIMETHYLAMINOBENZYLIDENEAMINO)- -1,2,4-TRIAZOLIUM BROMIDE SHOWING ANTIOXIDANT, ANTI-ISCHEMIC, β-ADRENOBLOCKING, UTEROTONIC AND DECREASING INTRAOCULAR PRESSURE EFFECTS | 1997 |
|
RU2136669C1 |
| LYSINIUM 3-METHYL-1,2,4-TRIASOLYL-5-THIOACETATE WITH NEUROPROTECTIVE, NOOTROPIC, CARDIOPROTECTIVE, ENDOTHELIOTROPIC, ANTI-ISCHEMIC, ANTIOXIDANT, ANTI-INFLAMMATORY AND ANTIHYPOXIC EFFECT AND LOW TOXICITY | 2007 |
|
RU2370492C2 |
| METHOD FOR PREDICTION OF RECURRENT MYOCARDIAL INFARCTION | 2010 |
|
RU2424531C1 |
| ANTI-ISHEMIC AND ANTIHYPOXIC AGENT | 2007 |
|
RU2356573C1 |
| GAMMA-HYDROXYPROPYLAMMONIUM-5-HYDROXYNICOTINATE ELICITING ANTI-ISCHEMIC, ANTI-ARRHYTHMIC AND HYPOLIPIDEMIC ACTIVITY | 2003 |
|
RU2245329C1 |
| METHOD FOR TREATING PATIENTS WITH CHRONIC HEART FAILURE AT THE BACKGROUND OF ISCHEMIC CARDIAC DISEASE | 2000 |
|
RU2213559C2 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR VARIOUS FORMS OF CHRONIC HEART DISEASE | 2010 |
|
RU2429489C1 |
| METHOD OF IMMUNE CORRECTOR THERAPY OF MYOCARDIAL INFRACTION IN RATS | 2010 |
|
RU2437165C1 |
| METHOD FOR REHABILITATION OF ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASES ACCOMPANIED BY CHRONIC HEART INSUFFICIENCY FOLLOWING MYOCARDIAL INFARCTION | 2014 |
|
RU2554756C1 |
